Yeztugo showed promising results in clinical trials. One study involving women in Africa reported 100% efficacy, with zero ...

The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that ...

The U.S. has approved the world's only twice-a-year shot to prevent HIV, maker Gilead Sciences announced Wednesday.

Lenacapavir, the world's first twice-yearly HIV prevention shot, gets US FDA nod-offering a discreet, long-acting solution ...

The U.S. has approved the world's only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that ...

The US FDA has approved lenacapavir, a biannual injection by Gilead, to prevent HIV, potentially revolutionizing the fight against the epidemic.

It's unclear how many people in the US and abroad will get access to the powerful new HIV prevention medication ...

June 19, 2025 – The FDA has approved the first twice-yearly shot to reduce the risk of HIV infections.

WASHINGTON (AP) — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step ... of new infections are in women, who often need protection they can use without ...

The approval could slow new infections and move the world closer to eliminating HIV. But huge obstacles remain.

WASHINGTON D.C., DC — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first ... of new infections are in women, who often need protection they can use without ...

The U.S. has approved the world’s only twice-a-year shot ... in HIV infections, while rates continued rising elsewhere. About half of new infections are in women, who often need protection ...